- Report
- October 2023
- 150 Pages
Global
From €4660EUR$4,850USD£4,007GBP
- Report
- August 2023
- 255 Pages
Global
From €4611EUR$4,799USD£3,965GBP
- Report
- February 2024
- 202 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- January 2024
- 213 Pages
Global
From €5285EUR$5,500USD£4,544GBP
- Report
- May 2024
- 192 Pages
Global
From €3242EUR$3,374USD£2,788GBP
€3602EUR$3,749USD£3,097GBP
- Report
- May 2024
- 180 Pages
Global
From €3242EUR$3,374USD£2,788GBP
€3602EUR$3,749USD£3,097GBP
- Report
- May 2024
- 185 Pages
Global
From €3242EUR$3,374USD£2,788GBP
€3602EUR$3,749USD£3,097GBP
- Report
- March 2024
- 133 Pages
Global
From €5717EUR$5,950USD£4,916GBP
- Report
- March 2024
- 128 Pages
Global
From €5285EUR$5,500USD£4,544GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- February 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- March 2024
- 182 Pages
Global
From €3242EUR$3,374USD£2,788GBP
€3602EUR$3,749USD£3,097GBP
- Report
- May 2024
- 762 Pages
Global
From €5573EUR$5,800USD£4,792GBP
- Report
- May 2024
- 334 Pages
Global
From €5381EUR$5,600USD£4,627GBP
- Report
- November 2023
- 110 Pages
Global
From €5717EUR$5,950USD£4,916GBP
- Report
- March 2024
- 147 Pages
Global
From €3746EUR$3,899USD£3,221GBP
- Report
- February 2024
- 250 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- October 2023
- 182 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- February 2024
- 120 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- January 2024
- 185 Pages
Global
From €4708EUR$4,900USD£4,048GBP
DNA vaccines are a type of genomics-based vaccine that uses genetic material from a virus or bacteria to stimulate an immune response. They are created by introducing a gene that codes for a specific antigen into a plasmid, which is then inserted into a host cell. The host cell then produces the antigen, which is then used to stimulate an immune response. DNA vaccines are considered to be safer than traditional vaccines, as they do not contain any live virus or bacteria. Additionally, they can be produced more quickly and cheaply than traditional vaccines.
DNA vaccines have been used to treat a variety of diseases, including influenza, malaria, and HIV. They have also been used to develop vaccines for cancer and other diseases. Recently, DNA vaccines have been used to develop vaccines for the prevention of infectious diseases, such as Zika virus and Ebola.
Companies in the DNA Vaccines market include Moderna, Inovio Pharmaceuticals, Novavax, and Transgene. Show Less Read more